Boston Scientific Elects David Habiger to Board of Directors
Rhea-AI Summary
Boston Scientific (NYSE: BSX) has announced the election of David Habiger to its board of directors, effective immediately. Habiger brings over 30 years of business leadership experience and currently serves as president and CEO of J.D. Power. He has previously led several technology companies and is a director on the Chicago Federal Reserve Board. Boston Scientific's CEO, Mike Mahoney, welcomed Habiger, citing his experience in leading technology companies through pivotal growth periods as a valuable asset to the company's board.
Habiger's extensive background includes founding Silicon Media Partners and serving as CEO for companies like Textura, NDS Group, and Sonic Solutions. He holds an M.B.A. from The University of Chicago and a bachelor's degree in business administration from St. Norbert College. His appointment is expected to contribute to Boston Scientific's ongoing efforts to deliver transformative healthcare solutions.
Positive
- Addition of an experienced business leader to the board of directors
- Potential for fresh insights from Habiger's technology sector experience
- Strengthening of the board's expertise in navigating growth periods
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, BSX declined 0.20%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Habiger has more than 30 years of business leadership experience and currently serves as president and chief executive officer of J.D. Power. Prior to joining J.D. Power in 2018, he founded and was a partner of Silicon Media Partners. Earlier in his career, he served as the chief executive officer for multiple private and publicly held technology companies including Textura, NDS Group and Sonic Solutions.
Habiger is a director on the Chicago Federal Reserve Board where he serves on the Governance, Human Resources and SABOR (Systems Activities, Bank Operations and Risk) Committees. He is also a director of several public and private boards and a member of the board of trustees at Rush University Medical Center. Habiger received an M.B.A. from The University of
"We are pleased to expand our board of directors with an accomplished executive who brings a wealth of experience leading technology companies through times of pivotal growth," said Mike Mahoney, chief executive and chairman of the board, Boston Scientific. "We welcome Dave and look forward to his insights as Boston Scientific continues to deliver solutions that transform lives."
About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and connect on LinkedIn and X, formerly Twitter.
CONTACTS | |
Media: | Investors: |
Chanel Hastings | Jon Monson |
508-382-0288 (office) | 508-683-5450 (office) |
Media Relations | Investor Relations |
Boston Scientific Corporation | Boston Scientific Corporation |
View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-elects-david-habiger-to-board-of-directors-302210247.html
SOURCE Boston Scientific Corporation
FAQ
Who is the new board member elected to Boston Scientific (BSX)?
What is David Habiger's background before joining Boston Scientific's (BSX) board?
How might David Habiger's experience benefit Boston Scientific (BSX)?
When does David Habiger's appointment to Boston Scientific's (BSX) board take effect?
